◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
TAIKO PHARMACEUTICAL CO.,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 26, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023
+Operating Income 482.0M -- -396.0M -396.0M --
Operating Margin % 91.3% -- 77.6% 77.6% --
+Ordinary Income 528.0M -- -510.0M -510.0M --
Revenue Growth % -- -- 0.0% -- --
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 26, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023
Current Assets 8.8B -- 9.1B 9.1B --
Total Assets 12.9B 13.0B 13.2B 13.2B 14.4B
Current Liabilities 2.9B -- 3.0B 3.0B --
Total Liabilities 4.9B 5.6B 6.5B 6.5B 6.5B
Total Equity 8.0B 7.4B 6.7B 6.7B 7.9B
Equity Ratio -- 0.57 -- -- 0.55
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...